The Slow Adoption of Neoadjuvant Treatment for Clinical T4b Colon Cancer: A National Cancer Database Analysis
Neoadjuvant therapy use has increased nationally, with a notable rise in immunotherapy for MSI-H tumors. Neoadjuvant treatment, particularly immunotherapy, is associated with significant overall survival benefit.
Authors
- Adam Truong (ORCID: https://orcid.org/0000-0001-9237-973X)
- Beiqun Zhao (ORCID: https://orcid.org/0000-0003-2181-3783)
Institutions
- University of California, San Francisco (US)
- Colon and Rectal Surgery Associates (US)
- Sinai Health System (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1002/jso.70093
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00